Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver

Author:

Li Xiaolei12,Tao Junyan23,Cigliano Antonio4,Sini Marcella4,Calderaro Julien56,Azoulay Daniel7,Wang Chunmei2,Liu Yan1,Jiang Lijie2,Evert Katja4,Demartis Maria I.8,Ribback Silvia4,Utpatel Kirsten4,Dombrowski Frank4,Evert Matthias4,Calvisi Diego F.48,Chen Xin23

Affiliation:

1. Department of Hepatobiliary Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, P.R. China

2. Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, CA, U.S.A

3. School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, P.R. China

4. Institute of Pathology, University Medicine of Greifswald, Greifswald, Germany

5. Department of Pathology, Assistance Publique-Hôpitaux de Paris, Centre Hospitalier Universitaire Henri Mondor, Créteil, France

6. Inserm, U1162, Génomique Fonctionnelle des Tumeurs Solides, Institut Universitaire d'Hematologie, Paris, France

7. Department of Digestive and Hepatobiliairy Surgery, Assistance Publique-Hôpitaux de Paris, Centre Hospitalier Universitaire Henri Mondor, Créteil, France

8. Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3